---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-22-261008"
form_type: "8-K"
ticker: "ACH"
cik: "0000075252"
company_name: "ACCENDRA HEALTH INC/VA/"
filed_at: "2022-10-12T23:59:59+00:00"
generated_at: "2026-06-23T04:11:14.164504+00:00"
event_type: "earnings"
sentiment: "negative"
materiality_score: 0.8
calibrated_materiality_score: 0.8
confidence: "high"
source: SEC EDGAR
---

# Owens & Minor cuts FY2022 guidance, announces executive reshuffle amid macro headwinds

## Summary
- Preliminary Q3 GAAP EPS $0.15-$0.17; adjusted EPS $0.39-$0.41.
- FY2022 adjusted EPS guidance cut to $2.50-$2.60 (prev. $2.85-$3.15); adjusted EBITDA $527-$537M (prev. $570-$610M).
- CFO Andy Long becomes EVP/CEO of Products & Healthcare Services segment; Alex Bruni promoted to EVP/CFO.
- COO Jeff Jochims resigns; separation agreement provides 1.5x salary and bonus severance.
- Weakness attributed to unfavorable macro, lower hospital volumes, and elevated customer stocking.

## SEC filing metadata
- accession: 0001193125-22-261008
- form_type: 8-K
- ticker: ACH
- cik: 0000075252
- company_name: ACCENDRA HEALTH INC/VA/
- filed_at: 2022-10-12T23:59:59+00:00
- event_type: earnings
- sentiment: negative
- materiality_score: 0.8
- calibrated_materiality_score: 0.8
- confidence: high
- sec_items: 2.02, 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/75252/000119312522261008/0001193125-22-261008-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/75252/000119312522261008/d390830d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-22-261008
- JSON: https://secwatch.observer/filing/0001193125-22-261008.json
- Plain text: https://secwatch.observer/filing/0001193125-22-261008.txt

## Key facts
- Executive change
  Alexander J. Bruni was appointed as Executive Vice President & Chief Financial Officer at ACCENDRA HEALTH INC/VA/.
  - Action: appointed
  - Role: Executive Vice President & Chief Financial Officer
  source text: Alexander J. Bruni, age 46, has been appointed Executive Vice President & Chief Financial Officer of the Company replacing Mr. Long effective October 12, 2022.
  evidence_url: https://www.sec.gov/Archives/edgar/data/75252/000119312522261008/0001193125-22-261008-index.htm
- Executive change
  Andrew G. Long was appointed as Executive Vice President, Chief Executive Officer of Products & Healthcare Services Segment at ACCENDRA HEALTH INC/VA/.
  - Action: appointed
  - Role: Executive Vice President, Chief Executive Officer of Products & Healthcare Services Segment
  source text: Andrew G. Long, the Company’s Executive Vice President & Chief Financial Officer has been appointed as Executive Vice President, Chief Executive Officer of the Company’s Products & Healthcare Services segment, effective October 12, 2022.
  evidence_url: https://www.sec.gov/Archives/edgar/data/75252/000119312522261008/0001193125-22-261008-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.